the Method of Cotton Padding Promoting the Rectovaginal Fistula Surgery

March 15, 2024 updated by: FENG Li-peng, China Academy of Chinese Medical Sciences

Research About the Method of Cotton Padding Promoting the Healing of the Wound After Rectovaginal Fistula Surgery

The method of Cotton Padding (mCP) was summarized by combining with many years clinical experience and the traditional ancient books.The mCP could be used in Rectovaginal Fistula (RVF) post operation effectively,in order to improve the wound.The research aim is to observe if the mCP could influence the time of staying in hospital, healing time after RVF surgery.

Study Overview

Detailed Description

The method of Cotton Padding (mCP) originating from extensive and profound traditional chinese medicine (TCM) and being one of traditional surgical treatments of chronic wounds,could promote the wound healing after RVF surgery in previous clinical experience.

The research aim is to observe if the mCP could influence the time of staying in hospital, healing time,quality of life,complications after RVF surgery.

Also,investigators will try to explain the mechanism about the mDM improving the wound healing by the chinese architectural theory and the nanomechanical properties.

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Beijing, China, 100053
        • Guang'anmen Hospital of China Academy of Chinese Medical Sciences
      • Beijing, China, 100195
        • Beijing Mayinglong Changqing Anorectal Hospital
      • Beijing, China, 102618
        • Southern District of Guang'an men Hospital,China Academy of Chinese Medical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Rectovaginal fistulae are rare and account for less than 5% of all anorectal fistulae[1,2].

The most common cause of RVF is obstetric trauma[2]. Trauma to the rectum, perineum,or vagina may cause RVF.The commonest form of trauma is during or following surgery, although blunt or penetrating trauma to the perineum or use of a foreign body in the vagina or rectum are well-recognized causes.The use of surgical stapling devices during stapled hemorrhoidectomy and stapled transanal rectal resections (STARR) have been implicated.

(© Springer Nature Switzerland AG 2021. G.A.Santoro et al. (eds.), Pelvic Floor Disorders, https://doi.org/10.1007/978-3-030-40862-6_79)

Description

Inclusion Criteria:

  • rectovaginal fistula because of parturition,stapler,traumatic injury.

Exclusion Criteria:

  • rectovaginal fistula because of IBD,radiation,cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
using the mCP
When the secretion reducing or the wound suture being removed, two pieces of 5cm×7cm-12p sterile gauzes will be crimped by the long side as the center of the reel,and be made as cylindrical gauze rolls with about D=1.5cm. After cleaning the wound, the cylindrical gauze rolls with its surface covered by alginates dressing will be placed above the vaginal wound with the help of endoscope.Itself tension of the rolls pressuring on the wound and the deep tissue can promote the wound healing. The rolls will be placed on about 5-6 hours every time, 2 times a day, for 7 days.Then observing the wound, if necessary, the method will be executed for another 7 days.
The method is to use gauzes folded onto the RVF wound surface to compact the deep wound so as to solid and durable,when the gauzes surface will be covered by alginates dressing.
Other Names:
  • the method of cotton padding with alginates dressing
no using the mCP
When the secretion reducing or the wound suture bing removed, only alginates dressing will be placed above the vaginal wound with the help of endoscope, without any pressure, being placed about 5-6 hours every time, 2 times a day, for 7 days.
Only alginates dressing will be placed above the RVF wound without any pressure.
Other Names:
  • only alginates dressing without the mCP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the time of healing
Time Frame: 28days-40days
the time of healing
28days-40days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the time of staying hospital
Time Frame: 7days-21days
the time of staying hospital
7days-21days
occurrence rate of complications
Time Frame: 1day-90days
occurrence rate of complications,including recurrence,blooding,wound dehiscence.
1day-90days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
the quality of life post-operation
Time Frame: 90days-180days
using the Wexner continence score (WCS) or the Vaizey score (VS) to assess the fecal incontinence,and using the Female sexual function index (FSFI) to assess the sex life,and aslo using the Clavien-Dindo classification(CDC) to assess other situation postoperatively.
90days-180days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: LI guodong, Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2022

Primary Completion (Actual)

March 15, 2024

Study Completion (Actual)

March 15, 2024

Study Registration Dates

First Submitted

November 15, 2021

First Submitted That Met QC Criteria

November 29, 2021

First Posted (Actual)

December 1, 2021

Study Record Updates

Last Update Posted (Actual)

March 18, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Individual participant data that underline the results reported in the article after identification, excluding the private information of participants.

IPD Sharing Time Frame

Becoming available after publication and ending 12 months following article publication.

IPD Sharing Access Criteria

Proposals should be emailed to venus59514@sina.com.To gain access, data requestors will need to sign a data access agreement and offer payment.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healing of the Wound After Rectovaginal Fistula Surgery

Clinical Trials on the mCP with alginates dressing

3
Subscribe